1. Home
  2. PRPL vs ONCY Comparison

PRPL vs ONCY Comparison

Compare PRPL & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Purple Innovation Inc.

PRPL

Purple Innovation Inc.

HOLD

Current Price

$0.74

Market Cap

89.8M

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.96

Market Cap

106.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRPL
ONCY
Founded
2010
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Home Furnishings
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.8M
106.1M
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
PRPL
ONCY
Price
$0.74
$0.96
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$1.00
$6.00
AVG Volume (30 Days)
223.4K
645.1K
Earning Date
11-04-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$457,012,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.69
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.56
$0.33
52 Week High
$1.29
$1.51

Technical Indicators

Market Signals
Indicator
PRPL
ONCY
Relative Strength Index (RSI) 43.10 45.03
Support Level $0.70 $0.94
Resistance Level $0.78 $1.00
Average True Range (ATR) 0.05 0.06
MACD -0.01 0.00
Stochastic Oscillator 16.42 26.16

Price Performance

Historical Comparison
PRPL
ONCY

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: